Enanta Pharmaceuticals
ENTA
ENTA
159 hedge funds and large institutions have $1.02B invested in Enanta Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 16 closing their positions.
Holders
159
Holders Change
+5
Holders Change %
+3.25%
% of All Funds
2.75%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
21
Increased
64
Reduced
48
Closed
16
Calls
$11.7M
Puts
$1.26M
Net Calls
+$10.5M
Net Calls Change
+$3.93M
Top Buyers
1 |
CC
1
Commodore Capital
New York
|
$5.37M |
2 |
2
BlackRock
New York
|
$188M |
3 |
![]()
3
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$18.3M |
4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$12.5M |
5 |
5
Barclays
London,
United Kingdom
|
$2.35M |